New retinoids and arsenic compounds for the treatment of refractory acute promyelocytic leukemia: Clinical and basic studies for the next generation

Cancer Chemotherapy and Pharmacology, Supplement

Volumn 40, Issue , 1997, Pages

  Kitamura, Kunio ^a   Kiyoi, Hitoshi ^a   Yoshida, Hitoshi ^a   Tobita, Tadasu ^c   Takeshita, Akihiro ^b   Ohno, Ryuzo ^b   Naoe, Tomoki ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NONE

Author keywords

Am80; APL; As2O3; ATRA; ATRA resistance

Indexed keywords

ARSENIC TRIOXIDE; RETINOIC ACID; RETINOID; TAMIBAROTENE;

ACUTE MYELOBLASTIC LEUKEMIA; ANIMAL CELL; CELL CULTURE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOTOXICITY; DRUG RESISTANCE; DRUG SENSITIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LEUKEMIA CELL LINE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RELAPSE; REMISSION;

ANTINEOPLASTIC AGENTS; ARSENICALS; BENZOATES; DRUG RESISTANCE, NEOPLASM; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; OXIDES; RECURRENCE; REMISSION INDUCTION; RETINOIDS; TETRAHYDRONAPHTHALENES; TREATMENT OUTCOME; TUMOR CELLS, CULTURED;

EID: 0030795945     PISSN: 09439404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (31)

1. Castaigne S, Chomienne C, Daniel MT, Ballerini P, Berger R, Fenaux P, Degos L (1990) All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood 76:1704
2. 4 cell apoptosis with downregulation of bcl-2 expression and modulation of PML-RARα/PML proteins. Blood 88:1052
3. Delva L, Comic M, Balitrand N, Guidez F, Miclea JM, Delmer A, Teillet F, Fenaux P, Castaigne S, Degos L, Chomienne C (1993) Resistance to all-trans retinoic acid (ATRA) therapy in relapsing acute promyelocytic leukemia: study of in vitro ATRA sensitivity and cellular retinoic acid binding protein levels in leukemic cells. Blood 82:2175
4. 3 analogs. Leuk Res 20:761
5. Dyck JA, Maul GG, Miller WH Jr, Chen JD, Kakizuka A, Evans RM (1994) A novel macromolecular structure is a target for the promyelocytic-retinoic acid receptor oncoprotein. Cell 76:333
6. Dyck JA, Warrell RP Jr, Evans RA, Miller WH Jr (1995) Rapid diagnosis of acute promelocytic leukemia by immunohistochemical localization of PML/RARα protein. Blood 86:862
7. Fukasawa H, Iijima T, Kagechika H, Hashimoto Y, Shudo K (1993) Expression of the ligand-binding domain-containing region of retinoic acid receptors alpha, beta and gamma in Escherichia coli and evaluation of ligand-binding selectivity. Biol Pharm Bull 16:348
8. Grignani F, Fagioli M, Alcalay M, Longo L, Pandolfi PP, Donti E, Biondi A, Lo Coco F, Grignani F, Pelicci PG (1994) Acute promyelocytic leukemia: from genetics to treatment. Blood 83:10
9. Hashimoto Y, Kagechika H, Kawaguchi E, Fukuzawa H, Shudo K (1995) Correlation of differentiation-inducing activity of retinoids on human leukemia cell lines HL-60 and NB4. J Cancer Res Clin Oncol 121:696
10. Huang ME, Ye YC, Chen SR, Chai JR, Lu JX, Zhoa L, Gu LJ, Wang ZY (1988) Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72:567
11. Huang SL, Guo AX, Xiang Y, Wang XB, Ling HJ, Fu L (1995) Clinical study on the treatment of APL mainly with composite Indigo Naturalis tablets. Chin J Hematol 16:26
12. Kagechika H, Kawachi E, Hashimoto Y, Himi T, Shudo K (1988) Retinobenzoic acids. 1. Structure-activity relationships of aromatic amides with retinoidal activity. J Med Chem 31:2182
13. Kanamaru A, Takemoto Y, Tanimoto M, Murakami H, Asou N, Kobayashi T, Kuriyama K, Ohmoto E, Sakamaki H, Tsubaki K, Hiraoka A, Yamada O, Oh H, Sato K, Matsuda S, Minato K, Ueda T, Ohno R, the Japan Adult Leukemia Study Group (1995) All-trans retinoic acid for the treatment of newly diagnosed acute promyelocytic leukemia. Blood 85:1202
14. 3+) and other metal ions on acute promyelocytic leukemia cells. Int J Hematol 65:179
15. Kizaki M, Ueno H, Yamazoe Y, Shimada M, Takayama N, Muto A, Matsushita H, Nakajima H, Morikawa M, Koeffler HP, Ikeda Y (1996) Mechanisms of retinoid resistance in leukemic cells: possible role of cytochrome P450 and P-glycoprotein. Blood 87:725
16. Kizaki M, Matsushita H, Takayama N, Muto A, Ueno H, Awaya N, Kawai Y, Asou H, Kamada N, Ikeda Y (1996) Establishment and characterization of a novel acute promyelocytic leukemia cell line (UF-1) with retinoic acid-resistant features. Blood 88:1824
17. Li YP, Said F, Gallagher RE (1994) Retinoic acid-resistant HL-60 cells exclusively contain mutant retinoic acid receptor-α. Blood 83:3298
18. Miller WH Jr, Jakubowski A, Tong WP, Miller VA, Rigas JR, Benedetti F, Gill GM, Truglia JA, Ulm E, Shirley M, Warrell RP Jr (1995) 9-cis Retinoic acid induces complete remission but does not reverse clinically acquired retinoid resistance in acute promyelocytic leukemia. Blood 85:3021
19. Morosetti R, Grignani F, Liberatore C, Pelicci PG, Schiller GJ, Kizaki M, Bartram CR, Miller CW, Koeffler HP (1996) Infrequent alterations of the RARα gene in acute myelogenous leukemias, retinoic acid-resistant acute promyelocytic leukemias, myelodysplastic syndromes, and cell lines. Blood 87:4399
20. Muindi JRF, Frankel SR, Huselton C, DeGrazia F, Garland WA, Young CW, Warrell RP Jr (1992) Clinical pharmacology of oral all-trans retinoic acid in patients with acute promyelocytic leukemia. Cancer Res 52:2138
21. Muindi J, Frankel SR, Miller WH Jr, Jakubowski A, Scheinberg DA, Young CW, Dmitrovsky E, Warrell RP Jr (1992) Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid "resistance" in patients with acute promyelocytic leukemia. Blood 79:299
22. Naoe T, Yoshida H, Kitamura K, Chino M, Osumi K, Ohno R (1995) Delayed and insufficient restoration of PML and PML-RARα subcellular localization after exposure in vitro to retinoic acids in all-trans retinoic acid-resistant APL cells. Leukemia 9:1610
23. Ohno R, the Leukemia Study Group of the Ministry of Health and Welfare (1993) Multi-institutional study of all-trans retinoic acid as a differentiation therapy of refractory acute promyelocytic leukemia. Leukemia 7:1722
24. Robertson KA, Emami B, Collins SJ (1992) Retinoic acid-resistant HL-60R cells harbor a point mutation in the retinoic acid receptor ligand-binding domain that confers dominant negative activity. Blood 80:1885
25. Sun HD, Ma L, Hu XC, Zhang TD (1992) Ai-Lin I treated 32 cases of acute promyelocytic leukemia. Chin J Integral Chin West Med 12:170
26. Takeshita A, Shibata Y, Shinjo K, Yanagi M, Tobita T, Ohnishi K, Miyawaki S, Shudo K, Ohno R (1996) Successful treatment of relapse of acute promyelocytic leukemia with a new synthetic retinoid, Am80. Ann Intern Med 124:893
27. Takitani K, Tamai H, Morinobu T, Kawamura N, Miyake M, Fujimoto T, Mino M (1995) Pharmacokinetics of all-trans retinoic acid in pediatric patients with leukemia. Jpn J Cancer Res 86:400
28. Warrell RP Jr (1993) Retinoid resistance in acute promyelocytic leukemia: new mechanisms, strategies, and implications. Blood 82:1949
29. Warrell RP Jr, The H de, Wang ZY, Degos L (1993) Acute promyelocytic leukemia. N Engl J Med 329:177
30. Weis K, Rambaud S, Lavau C, Jansen J, Carvalho T, Carmo-Fonseca M, Lamond A, Dejean A (1994) Retinoic acid regulates aberrant nuclear localization of PML-RARα in acute promyelocytic leukemia cells. Cell 76:345
31. Yoshida H, Kitamura K, Tanaka K, Omura S, Miyazaki T, Hachiya T, Ohno R, Naoe T (1996) Accelerated degradation of PML-retinoic acid receptor α (PML-RARA) oncoprotein by all-trans retinoic acid in acute promyelocytic leukemia: possible role of the proteasome pathway. Cancer Res 56:2945